— Know what they know.
Not Investment Advice
Also trades as: PFIZER.BO (BSE) · $vol 0M

PFIZER.NS NSE

Pfizer Limited
1W: -4.6% 1M: -17.3% 3M: -14.2% YTD: -22.2% 1Y: -32.3% 3Y: +4.0% 5Y: -32.7%
₹3,857.00 ($40.05)
-18.30 (-0.47%)
 
NSE · Healthcare · Drug Manufacturers - General · Tech Score Strong Sell · Power 29 · ₹176.4B mcap · 15M float · 0.289% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹176.4B ($1.8B)
52W Range3792.1-5578.5
Volume34,585
Avg Volume43,741
Beta0.12
Dividend₹75.00
Analyst Ratings
No analyst coverage
Company Info
CEOMeenakshi Nevatia
Employees1,244
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2002-07-01
The Capital
Mumbai, MA 400 051
IN
91 22 6693 2000
About Pfizer Limited

Pfizer Limited operates as a pharmaceutical company, engaged in the development, promotion, sale, and international export of medicinal products. Its diverse product range addresses numerous therapeutic needs, such as those related to the neuro/central nervous system, hormonal balance, cardiovascular health, hemophilia, infectious diseases, gynecology, pain relief, orthopedic conditions, oncology, urology, parasitic infections, gastrointestinal disorders, vaccinations, respiratory ailments, and nutritional supplements. The company markets its offerings predominantly under various brand names through an extensive network of independent distributors. Established in 1950, its corporate headquarters are situated in Mumbai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms